317 related articles for article (PubMed ID: 30838457)
21. Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Baumann P; Rochat B
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():15-21. PubMed ID: 7622807
[TBL] [Abstract][Full Text] [Related]
22. Vortioxetine: a New Treatment for Major Depressive Disorder.
Connolly KR; Thase ME
Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
[TBL] [Abstract][Full Text] [Related]
23. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
Dunham KE; Venton BJ
J Neurochem; 2022 Sep; 162(5):404-416. PubMed ID: 35736504
[TBL] [Abstract][Full Text] [Related]
24. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
[TBL] [Abstract][Full Text] [Related]
25. Systematic review and guide to selection of selective serotonin reuptake inhibitors.
Edwards JG; Anderson I
Drugs; 1999 Apr; 57(4):507-33. PubMed ID: 10235690
[TBL] [Abstract][Full Text] [Related]
26. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
Sproule BA; Naranjo CA; Brenmer KE; Hassan PC
Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
[TBL] [Abstract][Full Text] [Related]
27. Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Finley PR
Ann Pharmacother; 1994 Dec; 28(12):1359-69. PubMed ID: 7696728
[TBL] [Abstract][Full Text] [Related]
28. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
[TBL] [Abstract][Full Text] [Related]
29. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
30. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
[TBL] [Abstract][Full Text] [Related]
31. The six most widely used selective serotonin reuptake inhibitors decrease androgens and increase estrogens in the H295R cell line.
Hansen CH; Larsen LW; Sørensen AM; Halling-Sørensen B; Styrishave B
Toxicol In Vitro; 2017 Jun; 41():1-11. PubMed ID: 28179152
[TBL] [Abstract][Full Text] [Related]
32. Pharmacology and pharmacokinetics of citalopram and other SSRIs.
Baumann P
Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():5-11. PubMed ID: 8732438
[TBL] [Abstract][Full Text] [Related]
33. Serotonin reuptake inhibitors and breastfeeding: a systematic review.
Orsolini L; Bellantuono C
Hum Psychopharmacol; 2015 Jan; 30(1):4-20. PubMed ID: 25572308
[TBL] [Abstract][Full Text] [Related]
34. [Selective serotonin reuptake inhibitor(SSRI)].
Motohashi N
Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
[TBL] [Abstract][Full Text] [Related]
35. Metabolic interactions of central nervous system medications and selective serotonin reuptake inhibitors.
Naranjo CA; Sproule BA; Knoke DM
Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S35-47. PubMed ID: 10471171
[TBL] [Abstract][Full Text] [Related]
36. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence.
Womersley K; Ripullone K; Agius M
Psychiatr Danub; 2017 Sep; 29(Suppl 3):629-644. PubMed ID: 28953843
[TBL] [Abstract][Full Text] [Related]
37. Are pharmacokinetic drug interactions with the SSRIs an issue?
Brøsen K
Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():23-7. PubMed ID: 8732441
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitor exposure.
Fitzgerald KT; Bronstein AC
Top Companion Anim Med; 2013 Feb; 28(1):13-7. PubMed ID: 23796482
[TBL] [Abstract][Full Text] [Related]
39. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.
Vaswani M; Linda FK; Ramesh S
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):85-102. PubMed ID: 12551730
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
